arrow-small-left Created with Sketch. arrow-small-right Created with Sketch. Carat Left arrow Created with Sketch. check Created with Sketch. circle carat down circle-down Created with Sketch. circle-up Created with Sketch. clock Created with Sketch. difficulty Created with Sketch. download Created with Sketch. email email Created with Sketch. facebook logo-facebook Created with Sketch. logo-instagram Created with Sketch. logo-linkedin Created with Sketch. linkround Created with Sketch. minus plus preptime Created with Sketch. print Created with Sketch. Created with Sketch. logo-soundcloud Created with Sketch. twitter logo-twitter Created with Sketch. logo-youtube Created with Sketch.

Ask an Expert: Q&A – March 2021

Ask An Expert: Q&A | For health professionals 22 Mar 2021

'Ask an Expert: Q&A' is a place for health professionals to ask our team of experts about cases seen in work and/or clinical practice.

Questions can cover a wide range of women’s health topics and will be answered by an expert in the multidisciplinary Jean Hailes health professional team. Read more about this series or learn how to ask a question here.

If you are not a health professional but have your own health question, visit our 'Ask Dr Jean' pages.

Answering your questions for March's edition of 'Ask an Expert: Q&A' is Dr Elizabeth Farrell, gynaecologist and Dr Sonia Davison, endocrinologist.

Question 1

A woman with vasomotor symptoms consistently got migraines while on MHT. Escitalopram helped the hot flushes but seemed to exacerbate the night sweats. What are the options for non-hormonal treatment of vasomotor symptoms?


From Jean Hailes gynaecologist and medical director Dr Elizabeth Farrell (pictured)

In women with migraines, oral oestrogens are contraindicated and transdermal oestrogens would be prescribed.

In your patient, the MHT exacerbated her migraines. Gabapentin added to escitalopram may be effective in reducing her night sweats. Gabapentin has been shown to be as effective in some studies as oestrogen.

It is prescribed at night, improving sleep and reducing hot flushes and night sweats.

Clonidine has also been studied and may be effective.

Read more:

Question 2

When Prometrium is used as continuous MHT, why is it advised to take it for 25 days out of 28 rather than continuously? Is there any concern with taking it continuously without the 3 day break?


From Jean Hailes endocrinologist Dr Sonia Davison

The rationale behind taking micronised progesterone for 25 days in a 28 day cycle is based on the likelihood of bleeding, and is also based on the clinical experience of European prescribers long-term.

Unscheduled bleeding or spotting is thought to occur more frequently in the atrophic endometrium associated with continuous micronised progesterone use, due to VEGF production and an increase in the number and size of new vessels within the endometrium.

If women avoid progesterone for 3 days per month this is less likely to occur.

Do you have a women's health clinical question for one of our experts?

Go to 'Ask an Expert'

All rea­son­able steps have been tak­en to ensure the infor­ma­tion cre­at­ed by Jean Hailes Foun­da­tion, and pub­lished on this web­site is accu­rate as at the time of its creation. 

Last updated: 
18 January 2024
Last reviewed: 
25 May 2024